CXCL9 and neoplasm: IL-17 was reported to inhibit T cell attracting chemokines CXCL9 and CXCL10, thereby inhibiting the recruitment of CD8+ T cells and Treg cells in CRC, which helped the immune escape of tumor cells (59).